Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Kord Strebel, MD
EIR
•Kord Strebel, MD•August 25, 2021

Kord Strebel, MD – FDA EIR, Aug 25, 2021

Record Details

An FDA inspection of Dr. Kord T. Strebel, M.D., located in Las Vegas, NV, and associated with Women's Health Associates of Southern Nevada Central (WHASN)/Nevada Obstetrical Charity Clinic (NOCC), was conducted from August 10 to August 25, 2021. This IND-Initiated Clinical Investigator inspection aimed to assess compliance with Good Clinical Practice (GCP) guidelines and federal regulations for a clinical drug study. The inspection revealed several critical violations of the investigational plan and applicable regulations, resulting in the issuance of an FDA-483, Inspectional Observations. A primary concern was Dr. Strebel's significant lack of involvement and oversight in the study, with the Study Coordinator reportedly assuming full responsibility for various clinical trial activities without proper delegation or review. Specific issues included: vital signs measurements for three subjects performed outside protocol-mandated timeframes; physical examination source documents completed by an unqualified Study Coordinator without documented clinical investigator review; failure to perform required early termination procedures for four subjects (including an uncaptured endometrial biopsy for one and incomplete week 24 procedures for three others); and the absence of daily temperature logs for investigational product storage. Dr. Strebel acknowledged the observations and committed to providing a written response to address the deficiencies. He was reminded of the potential for legal sanctions if voluntary corrections are not implemented. The inspection highlighted a need for enhanced adherence to regulatory requirements and improved oversight in clinical trial conduct.

Company
Kord Strebel, MD
Inspection date
August 25, 2021
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Haydee Daclosan (investigator)
  • Rebecca Teves Davis (investigator)
  • Rebecca T. Davis (investigator)
  • Kord T. Strebel (recipient)
View Company Profile

ID · c26fa7b3-6723-4824-a601-bd5b9e25c11c

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Kord Strebel, MD
  • 483 - 2021-08-25August 25, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kord Strebel, MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.